Business Wire

TEMPO Commencing a Formal Process for a Significant Investment

Jaa

The Board of Directors of Nýherji hf. has hired AGC Partners, a global investment bank headquartered in Boston, MA, to initiate a formal process for a significant investment in TEMPO ehf, a wholly-owned Nýherji subsidiary.

Tempo’s solutions enable organizations to plan, optimize, and manage JIRA resources, budget and track project costs, and track and report time for back-office efficiency. The Company’s solutions solve key “white-collar” enterprise pain points around JIRA developer productivity, resource optimization, and time tracking as it unobtrusively collects data on calendars and tool usage in the background for the pre-population of time sheets. Tempo’s time management and budgeting tools have become essential products in the JIRA ecosystem and are well received by CIOs and CFOs looking to gain better clarity into time and resource usage and cost within their organization. Further, Tempo is consistently one of the highest rated and most downloaded add-on application within the Atlassian Marketplace.

Nýherji CEO, Finnur Oddsson, "Tempo's continued growth and success has been fueled by the team‘s singular focus on building a world-class product and organization. Following the development of Tempo Cloud for JIRA and the migration of over 7,000 customers over to Tempo's new cloud services on top of AWS (Amazon Web Services), a number of exciting growth opportunities have opened up, including integration with other cloud services in addition to JIRA by Atlassian. We think now is the right time to enhance Tempo‘s growth with a sophesticated investor that can help take the Company to the next level. For the past year, AGC Partners has advised on the strategic aspects of Tempo's operations and growth strategy and assisted with the general presentation of the Tempo to investors in the technology sector. AGC Partners will now commence Tempo's formal investment process, aiming to attract a financial partner with extensive experience in growing software companies internationally. We believe this will best enable the continuation of product development at Tempo, its revenue growth, and value for owners, employees and customers."

Nýherji hf.

Nýherji is one of Iceland’s largest providers of information technology solutions, offering hardware, software, consultancy, and technical services. Nýherji has over 1,000 clients and helps our customers achieve the best results for their businesses with the help of IT services through our staff's expertise and quality service. Nýherji hf. is registered in NASDAQ OMX Iceland hf. under the symbol NYHR.

TEMPO

Tempo is a leading provider of time management and budgeting software, transforming time and resource tracking for increased back-office efficiency with smart work management solutions. Tempo's customers are companies around the globe, from startups to Fortune 500 companies including BMW, Pfizer, HomeAway, PayPal, Hulu, Dell, Mercedes Benz, Starbucks, and Disney. Tempo is a whole-owned subsidiary of Nýherji Group. Tempo employs around 100 staff, both in Iceland and in North America. Visit www.tempo.io for more information.

For the attention of investors

Nýherji Group wishes to notify investors that statements made in this press release may be based on the current expectations, forecasts and assumptions of the company's executives and not facts subsequently verifiable by the publication of this press release. Such statements are naturally subject to future risks and uncertainties. We wish to notify investors that a number of factors could cause the company's business environment to differ materially from current expectations as assumed in the press release. This press release will not be revised after its publication in this regard. Any statement made in this press release is valid only at the point of its publication, and its validity is restricted in accordance with this clause.

Contact information

Further information
Finnur Oddsson, Nýherji CEO
+354 862 0310
fo@nyherji.is,
or
Gunnar Petersen, Nýherji CFO
+354 825 9001
gp@nyherji.is
or
Frederick Joseph at AGC Partners
+001 617 261 4150
fjoseph@agcpartners.com.

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 20:21Tiedote

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 19:00Tiedote

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 15:38Tiedote

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 15:05Tiedote

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d

Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 15:00Tiedote

Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste

Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport18.7.2018 12:05Tiedote

Smiths Detection has been selected by Finnish airport operator, Finavia Corporation, to support the transition to Standard 3 at Helsinki Airport with approved hold baggage screening systems. Included in the contract are eight high-speed, HI-SCAN 10080 XCT scanners, which combine high resolution X-ray technology, computed tomography (CT) and advanced detection algorithms to increase both security and operational efficiency significantly. Security, speed and efficiency are critical to the extensive development programme underway at the airport, which will allow the airport to serve 30 million passengers annually and increase baggage handling capacity by 50%. “Any financial investment in upgrading security equipment has to be balanced against operational improvement, particularly when part of a major expansion. Airports need assurance that efficiencies will be gained and systems can be further updated as necessary to detect evolving explosive threats and handle ever higher volumes,” comme

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme